Social commerce Open Innovation in healthcare management: an exploration from a novel technology transfer approach by Gareth, Davies et al.
 




This is an author produced version of a paper published in: 
Journal of Strategic Marketing 
 





Davies, G., Roderick, S. & Huxtable-Thomas, L. (2018).  Social commerce Open Innovation in healthcare 








This item is brought to you by Swansea University. Any person downloading material is agreeing to abide 
by the terms of the repository licence. Copies of full text items may be used or reproduced in any format 
or medium, without prior permission for personal research or study, educational or non-commercial 
purposes only. The copyright for any work remains with the original author unless otherwise specified. 
The full-text must not be sold in any format or medium without the formal permission of the copyright 
holder. 
 
Permission for multiple reproductions should be obtained from the original author. 
 
Authors are personally responsible for adhering to copyright and publisher restrictions when uploading 






Social commerce Open Innovation in healthcare management: an exploration from a novel technology 









This paper presents an Open Innovation approach, AgorIP, for commercialisation of opportunities within 
Health & Social Care and Life Sciences, piloted in south west Wales. This approach, supported by Welsh 
Government, NHS Wales, universities and private sector aims to develop new markets and innovations, 
where all opportunities are rigorously assessed for existing and/or new market potential. In parallel, the 
empowerment of citizens to manage their personal and collective health, and to access information and 
services has become an important driver, becoming a disruptive development within the state-centric 
integrated health economy. This paper examines the relevant policy context and emerging portfolio of 
innovations within AgorIP to explore emergence of social commerce innovation in Healthcare 
management. Findings reflect the above dynamics and constraints, with innovations showing 
segmentation across geographic, demographic and disease-sufferer groups. The authors therefore offer 
the AgorIP initiative as an interesting space to observe the potential for Open Innovation of social 
commerce within the health sector. 
 




The precursor to the UK National Health Service (NHS), with Welsh miners contributing to a collective 
welfare and health scheme purchasing services from then exclusively private-sector health practitioners, 
could be regarded as a form of ‘pre-Internet’ social commerce. However, its modern form is now 
struggling with growing demand and expectations including notable pressures from demographic 
change, while also grappling to benefit from digital and social revolutions.  
 
The potential for innovation to transform healthcare is well-established (Ferlie and Shortell, 2001), while 
more recently the opportunities for Open Innovation (Chesbrough, 2003) in the sector, and potential 
approaches for its application have been proposed by NESTA (2017). However, public-sector healthcare 
systems have not yet embraced the paradigm as effectively as, for example, the private sector drug 
development that supplies them (Talaga, 2009). Within this agenda, E-health is a long-standing term, the 
roots of which are helpfully defined by Eysenbach (2001) as including Empowerment, Equity and 
Enablement for patients, though in a pre-Web 2.0 era this applied more-so to provision of information 
than service delivery. However, the implied transfer of power from health service provider to patient 
has already established clear parallels with the more recent Web2.0-enabled social commerce power 
transfer “from sellers to buyers” described by Hajli and Sims (2015). 
 
While NHS Wales may not exhibit the challenging fragmented nature of the US system described by 
Herzlinger (2006), it does still involve; significant regulation; a fixed (not just rigid) business model 
(Hwang and Christensen, 2008); public procurement constraints (Uyarra et al., 2014); and stringent 
patient confidentiality. It certainly poses some tougher questions with regard to market orientation than 
those facing other public services (Hodgkinson et al., 2012). These are all challenges which act to reduce 
absorptive capacity and the ‘porousness’ of walls for innovation into the public healthcare system.  
 
However, the inherent potential for digital technologies to support innovation in health and social care 
is central to Welsh Government (WG) policy (WG, 2015), with ‘co-production’ of health outcomes at its 
centre. This co-production approach is described as being ‘at an individual and population level where 
patients and the NHS each make a contribution to improve health and wellbeing’ where ‘service 
providers and users, work together to create and deliver services’ (Bevan, 2015). These ambitions, 
together with national (WG, 2015) and local (Abertawe Bro Morgannwg University Health Board) 
(ABMUHB, 2017) strategies include planned engagement of patients through social networks, both as 
individuals and groups. This WG policy agenda focuses on digitization of NHS services and patient 
information, though with limited ‘social’ scope beyond that of enabling discussion within patient groups. 
In this regard, its ambition misses the scope of social commerce. Indeed, stated within the Strategy is 
that, “People will use digital channels, such as social media and apps, to share their knowledge and 
experiences and, if desired, engage with a wider social network”, though not explicitly to commission 
their own care or provide care to others.  
 
In the above state-centric context, the social commerce concept may not readily align with the public-
sector-supply dominated health sector, however, its ‘co-production’ ambition resonates with the 
cocreation of value and relationships described by Vargo and Lusch (2004), and the transfer of power 
from sellers (medics) to buyers (patients) presented by Hajli and Sims (2015). It also echoes the 
description of value co-creation provided by Prahalad and Ramaswamy (2004), which includes the 
example of patient-doctor interaction. The co-production concept, from service design to delivery is also 
reflected in the aforementioned health service strategies (WG, 2015) (NHS, 2015). This healthcare 
application of the term implies both the co-creation of value (in this case health outcomes) and the 
process of their co-production, which relates to the debate presented by Lusch and Vargo (2006). This 
debate sits alongside broader challenges, including definition of the co-production term within its wider 
application noted by Boyle and Harris (2009). This is reflected in its local use within the Healthcare 
domain, where for example the independent Welsh Health think-tank (Bevan, 2015) has combined its 
original co-production goals with those of equality of access and effectiveness of practice. 
 
In parallel with the above evolving health system context, social marketing (Grier and Bryant, 2005, 
Craig Lefebvre and Flora, 1988) through digital media has long been established in promotion of public 
health agendas, though e-commerce remains limited to transactions within/amongst provider 
organisations. The prospect for citizens establishing themselves as health providers akin to the sellers 
suggested by Stephen and Toubia (2010), may understandably be somewhat less anticipated than for 
retail and other services. The importance of trust in online health advice and other services provides 
bias towards established sources/providers with trustworthy provenance, with credible presentation of 
information among key factors in its adoption (Sillence et al., 2006) (Lederman et al., 2014). Again, this 
echoes the observation of social commerce adoption consistently centring upon trust (Hajli, 2013, Hajli, 
2015, Lu et al., 2016, Shanmugam et al., 2016).   
 
While not attempting to simply map health co-production, from diagnosis to treatment and aftercare, 
against the stages of Co-production described by Etgar (2008), it is clear that the broader value co-
creation reflects the basic concept presented by Prahalad and Ramaswamy (2004) (below), albeit with 
health outcomes rather than economic value as its purpose.  
 
Fig.1 : Co-creation market concept (Prahalad and Ramaswamy, 2004)  here  
 
South west Wales: life sciences & health  
 
Harnessing the potential of Life Sciences & Health innovation, particularly for the combined goals of 
improved population health and economic development has been a long-standing ambition in south 
west Wales (Davies et al., 2018). The region was at the epicentre of the first industrial revolution 
through its vast coal and steel industries (Mathias, 2013). However, these sectors declined over time 
with major contraction during the 1970s/80s (Morgan, 2001). In response to employment loss, this led 
to a concerted, and initially highly successful strategy (Heidenreich et al., 1998) of targeting and 
attracting significant inward-investment, primarily for multinational manufacturing facilities. 
International competition eroded this success, and the attention of the recently formed Welsh Assembly 
Government turned to development of an indigenous knowledge-based economy (WAG, 2004b). This 
strategy became increasingly sectors-focused, targeting high-growth areas, including ICT, Advanced 
Manufacturing, and Life Sciences & Health (WG, 2013).   
 
The Life Sciences sector in Wales employs ~10,000 people contributing £2bn GVA though in comparison, 
the local National Health Service (NHS) providers, Abertawe Bro Morgannwg (ABMUHB) and Hywel Dda 
University Health Boards (as part of the ARCH A Regional Collaboration for Health initiative) employ 
some 30,000 individuals across a broad range of professions (ARCH, 2017), in addition to wider general 
practice, pharmacy and other health services. This regional imbalance towards public-sector 
employment does though reflect in innovation potential from Life Sciences & Health noted within the 
Regional Innovation System by Cooke (2004a), (2004b), and explicitly in the context of the Regional 
Innovation System (Davies et al., 2015 ).  
 
Recent years have seen significant investment into Life Sciences & Health within the region (WEFO, 
2014), including specific focus on health & bio-informatics, and medical devices, reflecting regional 
‘smart specialisations’ (Commission, 2017). Previous study of the regional sector has also demonstrated 
how Life Science & Health innovation can benefit wider sectors, including specifically ICT and Advanced 
Manufacturing (Davies et al., 2017). This activity has aimed to develop a cluster originally identified in 
2001 (DTI, 2001). The recently approved Swansea Bay City Region City Deal refers to these endeavours 
and the associated infrastructure as a foundation for its planned ‘Internet of Health and Wellbeing’, 
which includes development of a ‘Campuses and Villages’ network across the region. The aim of this 
network is to provide nodes specialising as follows (SU, 2017);  
 
- A Singleton Campus (at the Swansea University Singleton Campus / ILS 1&2 / Singleton Hospital site) 
focusing on low TRL (Technology Readiness Level) activity in a range of Life Science & Health innovations, 
including eHealth and telemedicine, making use of unique datasets/connectivity. This sits alongside core 
ILS incubation and business facilities, which aims to expand through the planned Healthcare Technology 
Centre for low-volume pilot and specialist manufacture.  
- A Morriston Campus (at the Morriston Hospital site) which is intended to support innovation in acute and 
hospital-based applications with focus on high TRL translational activity for both indigenous and inward-
investing activities. Technology transfer through ILS is to be supported through a pan-Wales service 
(AgorIP) for which Morriston is identified as offering greater potential clinical engagement.  
 
These nodes sit within the broader regional ambition to create an ‘Internet Coast’ centred on 
development of next generation services including in the field of Health & Social Care (SU, 2017).  Such 
planned, rather than spontaneous cluster development including specifically in life sciences, has been 
examined by Chiaroni and Chiesa (2006) and (Su and Hung, 2009), with some researchers questioning 
the effectiveness of such approaches (Swords, 2013), or at least understandings thereof (Ketels, 2013). 
 
In this regional and sectoral context, ABMUHB recently launched a Digital Strategy (ABMUHB, 2017), 
which includes further digitization of the organization, though centred upon an ostensibly co-production 
platform, with user journeys structured by Support Me, Assess Me, Treat Me, and Coach Me, with 
emphasis on patient involvement/action. The ABMUHB Digital strategy explicitly describes involving 
patients individually and collectively creating, sharing and utilizing content related to health and care 
with emphasis on co-creation, including services “brought into public use by other (read private and 
third sector) organisations”. This points to ambition for strategic co-creation of the manner suggested 
by Mostafa (2016), albeit in a different sector to that involved in their research. The relative monopoly 
of the public health service in this context does though suggest ambition for efficiency and effectiveness 
rather than competitive advantage.  
 
The ABMU Digital Strategy (ABMUHB, 2017) has embraced the development and application of patient-
centric tools such as ‘Patient Knows Best’ as part of its delivery. However, at this stage, such endeavours 
remain focused upon internal workflows and interaction with individual patients. Therefore, the strategy 
looks beyond the organisation to identify sources of innovation to create further digital services. One 
such source, embedded within the Internet Coast is AgorIP (SU, 2016), an initiative which aims to 




This study reviews the AgorIP portfolio for development of social commerce innovation, using the 
approach presented below adapted from Stake (1995), and applied by Huxtable-Thomas et al. (2015) to 
examine an ESF-supported project. This approach allows further development, including through a 
planned longitudinal study. 
 
Fig. 2: AgorIP Model and Review - here 
 
The study exists in the relevant contexts of Technology Transfer, Social Commerce, Regional Innovation 
Systems and Welsh Government Economic and Health Policies, applying mixed methods (Creswell and 
Clark, 2007) involving; 
 
• Review of the original AgorIP project proposal/model in the context of Technology Transfer; and 
• Review of current and emerging AgorIP project portfolio 
The above framework also supports integration of further data and methods to build upon the study, 
including longitudinally, as well as providing a basis for planned examination of the cases of individual 
innovations emerging from the initiative.  
 
As a European Regional Development Fund (ERDF)-supported project (WEFO, 2013), AgorIP maintains 
detailed records of its activities. These records, together with the project business case and supporting 
documentation provide the basis of this study.  
 
AgorIP: Open Access Open Innovation Technology Transfer 
 
Universities, globally and specifically in the UK and Wales, have long been recognised as important 
economic actors, with continued discussion as to how University-Industry interaction and impact can be 
optimised (Youtie and Shapira, 2008, Lambert, 2003) (WAG, 2004a), though sometimes challenging the 
extent to which universities are relevant (Power and Malmberg, 2008). University-Industry relations, 
including through networks of enterprises large and small, and research hospitals have been shown as 
important drivers of innovation in Life Sciences & Health (Owen-Smith et al., 2002). This has greater 
importance in south west Wales with comparatively low levels of local Business Expenditure on R&D 
(Rogers, 2006). Such relationships are complex with one type of linkage relating to or resulting in 
another (Dechenaux et al., 2011).  
 
Technology transfer exists in this broader context of University-Industry engagement, and has been 
demonstrated as an important part of this contribution (Tornatzky and Association, 2000), spurred in 
the US by the Bayh-Dole Act (Henderson et al., 1998, Jensen and Thursby, 1998), along with a range of 
other factors (Mowery et al., 2001). In the UK the agenda has received particular interest from a 
government policy context since reviews by UK (Lambert, 2003) and regional Welsh (WAG, 2004a) 
Governments.  
 
A comprehensive review of university Technology Transfer practice and literature is provided by Bradley 
et al. (2013),including the observation that oversimplification of the processes involved fail to account 
for many key factors. The process of technology transfer has historically been considered as 
unidirectional and linear (D’Este and Patel, 2007), and reflected as such in models such as that 
presented by Siegel et al. (2004) in Fig.3 below.  
 
 
Fig. 3: Linear Technology Transfer Process (Siegel et al., 2004) - here 
 
The greater complexity of Technology Transfer presented in Bradley’s Alternative model (2013), echoes 
the trend towards recognition of increasing complexity seen in other models such as the triple helix 
(Etzkowitz and Leydesdorff, 1995), which is now accompanied by quadruple and n-tpule (Leydesdorff, 
2012) models. This complexity and greater interplay of actors represents the broader Open Innovation 
space within which AgorIP aims to nurture innovation through technology transfer within south west 
Wales. The Open Innovation (Chesbrough, 2003) dynamics between universities and industries are 
discussed as being within a complex mix of mechanisms supporting and enabling University-Industry 
relationships (Perkmann and Walsh, 2007), while Bradley et al. (2013) describes this with particular 
respect to Technology Transfer.  
 
Delivering efficiency in Technology Transfer Offices (TTOs) has been examined by Anderson et al. (2007), 
observing significant variation in performance, and suggesting a number of factors for consideration, 
including scale, variation in policies and incentive structures. In line with this, over the past decade it has 
been proposed by both researchers (Siegel et al., 2003) and policy-makers (WAG, 2004a) that UK 
(including Welsh) TTOs would benefit from greater regional and sector focus, while also recognising the 
challenge of achieving effective and sustainable scale of activities.  
 
Responding to the challenges and opportunities of healthcare innovation and technology transfer, 
Welsh Government and NHS (ARCH, 2017 #267) partners have worked to develop the ‘AgorIP’ initiative. 
The Agor (Welsh language for ‘Open’) Intellectual Property initiative, AgorIP, has been developed as an 
‘Open Access Open Innovation’ model to create a pan-Wales Technology Transfer Office for Life Sciences 
& Health innovation drawn from sources including Higher Education, NHS Wales and the private sector 
(SU, 2016). Co-funded by Welsh Government Department for Health and Social Services, the initiative is 
targeting 50% of its innovations to be realised in the sectors of Life Sciences, and Health & Social Care.   
 
The AgorIP model reflects the Alternative Model of Technology Transfer proposed by Bradley et al. 
(2013), though with a ‘zero waste’ approach that aims to reduce the parallel channel outside the TTO 
and to maximise return from all opportunities.  It also explicitly incorporates the function of the TTO into 
a wider set of organisations in providing service to research and innovation activities within the regional 
public health system. The zero-waste philosophy proposes that all disclosures are progressed with 
resource invested proportionate to the opportunity identified, along the most appropriate pathway (SU, 
2016) (fig. 4 below).  
 
Fig. 4: AgorIP Commercialisation Pathways - here 
 
The multiple pathways aim to accommodate the targeted Open Innovation dynamics, drawing 
opportunities from diverse sources (academia, health service and private sector), at a range of stages 
(presented by TRLs), and arriving at diverse planned and anticipated markets. Pathways are identified 
and developed collaboratively between stakeholders as a Co-production process (SU, 2016). D’Este and 
Patel (2007) suggest that TTO mechanisms of patenting and spin-out may attract disproportionate 
attention, though AgorIP aims to avoid such bias by integrating with wider University-Industry 
engagement mechanisms such as consultancy and knowledge transfer offerings.  
 
Further features that claim to support greater potential Open Innovation and Co-production activity 
include harmonisation of organisational policies, including for management of Intellectual Property 
between NHS Bodies (including Health Boards) and Swansea University (SU, 2016). Such an arrangement 
partially responds to one of the more UK-specific challenges identified by Decter et al. (2007) where 




The case reviewed the AgorIP project at September 2017 when it had been underway for 12 months, 
including its initial ‘mobilisation’. At this point it had developed a portfolio of 111 opportunities across a 
range of sectors. Clearly, as opportunities take time to develop this portfolio relates to the input, rather 
than successful innovation. 5 opportunities had already progressed to become spin-out companies 
attracting external investment, with a further 15 resulting in licensing arrangements.  
 
From this portfolio, 46 opportunities (41%) related to Health & Life Sciences, with 14 (13%) in the E-
Health domain. These opportunities included a broad variety of disease diagnostic technologies and 
medical device inventions, reflecting academic research strengths in Swansea University. Just over half, 
(8 of 14) opportunities within the E-Health domain exhibited the dual social commerce elements of 
social media and e-commerce. Of these, almost all (7 of 8) originated from individuals/groups outside 
the health service.  
 
As the project and therefore the pipeline is still at an early stage, most opportunities had not matured to 
‘success’ or ‘failure’, or at least to any extent beyond noting those which have been licensed or spun-
out. While significance of origins, pathways and success cannot be statistically tested, the emergent 
portfolio does suggest a preponderance towards health economy social commerce opportunities 
emerging from outside the health system.  
 
Due to the nature of many opportunities there are commercial sensitivities that require confidentiality, 
governed by Non-Disclosure Agreements between stakeholders. Therefore, not all further details 
available within AgorIP records cannot be disclosed. However, examples of opportunities providing non-
confidential information include; 
 
‘Diet or Disorder’ An App which is one of the first innovations to emerge from AgorIP, with the aim of 
empowering members of the public to seek diagnosis and other support for eating disorders. The App is 
an example of ‘co-production’ with the user engaged in their diagnosis, and management of conditions 
including through social (patient) networks. Developed with clinicians from Aneurin Bevan University 
Health Board, the App adheres to national guidelines and has been launched on the Apple iTunes store.    
 
‘Yada’, A platform to promote social inclusion which has been developed with a social entrepreneur 
aiming to enhance accessibility to tourism and leisure venues ranging from individual restaurants to 
entire towns, for individuals living with conditions. Engaging disability groups through social media, the 
platform will allow users to share information and reviews on how destinations cater for users’ needs. 
Initially focused on the south west Wales region, the App brings together Health & Wellbeing and 
Leisure & Tourism sectors.   
 
This adds to existing innovations developed with the ABMU Health Board such as PocketMedic, which 
provides ‘social prescribing’ of videos and other resources to support patients. However, at present this 
and other local e-Health innovations remain relatively transactional between health service and 
individual patient, reflecting more traditional e-commerce rather than social commerce.   
 
Other, non-Life Sciences & Health social commerce innovations are also emerging through AgorIP. These 
include;  
‘DigiCat’, an online portal for course and module selection. The portal provides a marketplace for 
modules/courses amongst students, lecturers and support staff. The portal is used for presenting 
information, sharing student experiences, and allowing selection of modules. This clearly does not 
involve the regulatory or other challenges faced within healthcare, and has already been launched.   
Conclusion 
 
While still at an early stage, the AgorIP portfolio already presents ICT-driven innovations relating to 
health and social care, including a number with patient-focus and examples of social commerce. This 
demonstrates the potential for social commerce innovation in health to emerge from the Technology 
Transfer approach. However, it remains to be seen whether, or at least how, the state-centric market 
structure for health innovation will allow significant social commerce innovation to emerge. The 
‘marketplace’ proposed by the ABMUHB Digital Strategy provides a potential location for social 
commerce where trust stems from the NHS Wales involvement, and would involve moving beyond 
digitisation of existing service models.  
 
AgorIP presents a novel mechanism for commercialisation though co-creation of innovation, and 
provides an interesting testbed for future study. It demonstrates Open Innovation as an approach to 
orchestrating opportunities emerging from a variety of sources and also highlights a route to tackling 
the perennial challenge of absorptive capacity in core components of the health system. Developing this 
approach could therefore provide benefit to policy-makers and practitioners keen to realise the dual 
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